Miragen Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $117M | 5.4M | 21.58 |
| 2025-06-30 | $77M | 5.5M | 13.98 |
| 2025-03-31 | $77M | 5.7M | 13.48 |
| 2024-12-31 | $110M | 5.8M | 19.17 |
| 2024-09-30 | $109M | 4.8M | 22.75 |